Aquea Scientific Corporation

Aquea Scientific Corporation’s mission is to leverage unique and patented delivery systems to enhance and differentiate internal and customer’s products in consumer, commercial and industrial markets. Our success relies on a proactive entrepreneurial workforce dedicated to safety, quality, and innovation focused on customer satisfaction. The goal is to grow the company into an industry leader known for integrity, innovative solutions and strong customer and employee loyalty.

Daniel H. Traynor
Chief Scientist

Dan Traynor is the inventor of the revolutionary Aquea Delivery System™. Dan’s research history includes the study of rapid penetrating creams and gels, new combinations of polymers and phospholipids-based products, and pharmaceutical and skincare delivery systems. From 1995 to 2004, Dan was Director of Sunsation Tanning Products, Inc., a designer and manufacturer of skin and hair care products, including its own brands and private label products for celebrity clients and distributors in the U.S. While at Sunsation, Dan also created SunBar, a solid sunscreen that could be used in the shower. Dan’s extensive background includes the development of new flavors and researching problems associated with product stability. He has designed sunscreen and skincare delivery systems, including the implementation of phospholipids technology. Consumer products developed by Dan have included shampoos, conditioners, moisturizers, exfoliators, self tanners, sunscreens and sun blocks as solids, liquids and gels. He also has managed FDA compliance of these products, including researching new drug registration. Dan’s manufacturing experience includes designing equipment for high and low viscosity-based formulations, implementing quality control programs, and setting manufacturing guidelines for standard operating procedures.

 

Martin S. Flacks
Chief Operations Officer

Marty came to Aquea with over 30 years experience in cosmetics, fragrance and personal care. A registered Pharmacist, he worked as a Chemist at Lehn & Fink Products developing OTC, cosmetic and fragrance products and moved to Ortho Pharmaceutical as a Scientist where he also served as a Teaching Associate for the Rutgers University College of Pharmacy Externship Program. In 1984, he became Manager of R&D at Warner Cosmetics – at the time, the leading U.S. fragrance company. When acquired by L’Oréal, Marty progressed from Manager of Skin Care and Fragrance R&D to R&D/Marketing Liaison to Marketing Brand Manager, Giorgio Armani Fragrances. In 1988, he joined Calvin Klein Cosmetics Company as Director of R&D, which became Unilever Cosmetics International. As Vice President Global Product Development and Quality Assurance, Marty was responsible for the development of new products, brand maintenance, pilot scale-up and manufacture of all bulk product. He also set the standard for scientific integrity and ethical performance of products and staff, assuring product integrity and safety for all UCI products. After UCI was acquired by Coty, Inc., Marty became intrigued by Aquea’s breakthrough technology and began consulting in April 2006, becoming a full time member of the team in June. Marty is a member of the Southern California Chapter of the Society of Cosmetic Chemists.

 

Kevin McGovern
Chief Strategist and Chairman, Advisory Panel

Kevin is a recognized leader in skin care intellectual property and licensing strategy. He is a rights holder in and coordinates the worldwide licensing program for NeoStrata Inc., which has generated more than 80 patents on the uses and compositions of hydroxy acids. Their mainstay Alpha Hydroxy Acids (AHAs) have been incorporated into approximately 40% of all skin-care products worldwide. The licensing program implemented and standardized by Kevin has resulted in the issuance of more than 40 licenses to such companies as Avon, Beiersdorf, Bristol-Myers Squibb, Chanel, Estee Lauder, Johnson & Johnson, L'Oréal, and Neoteric. Kevin has been a principal negotiator/participant to over 40 strategic alliances, approximately 40% of which have been foreign joint ventures. Mr. McGovern is the principal of McGovern & Associates which specializes in corporate law and intellectual property strategy with an emphasis on emerging businesses, mergers and acquisitions, securities, patent enforcement, corporate and partnership joint ventures, capital formation and R&D financing. He has spoken around the world at various venture, business, and educational meetings regarding capital formation, patent enforcement and maximization of intellectual property value, business alliances, and ventures. As a director of New York Business Roundtable Inc., the U.S. market leader in high-quality business forums, he has brought together financial executives and senior business people.